Match details
Record ID:
NRN_AR207828
Database:
nrnl1
Go to original record
Description:
Sequence 21 from patent US 6379926. Sequence 21 from patent US 6815420. Therapeutic Compositions and Methods for Treating Disease States with Mutant Forms of Myeloid Progenitor Inhibitory Factor-2 (MPIF-2).
Taxon:
unidentified
Original size:
4256 bp
Patents:
US6379926 (lens , espacenet )
US6379926 (lens , espacenet )
US6815420 (lens , espacenet )
US2003059874 (lens , espacenet )
JP2003528815 (lens , espacenet )
View other 1 match for this record
View other 59426 matches for this method
Predicted amplification details:
Mismatches
Gaps
From
To
Strand
Amplicon size
0
0
3379
3593
-
215 bp
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg
51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa
101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc
151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc
201 gccaggctca aggcg
View other 57490 matches with an identical amplicon
Primer/Probe
% Identity
Length
Mismatches
Gaps
From
To
Score
primerA
100.0
21 bp
0
0
1
21
3.06e-09
primerB
100.0
21 bp
0
0
215
195
3.06e-09
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.